Provider review · Public documents checked September 27, 2026
The Ordinary copper-peptide serum review: what its formula adds to the comparison
Examine the current 30 mL offer, published ingredient declaration and product-specific cautions without mistaking a serum for a face cream.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
A copper-peptide serum is rarely just copper peptide in a bottle. Water, moisturizing ingredients, other peptides and formulation aids all belong to the finished product a person encounters. Reading only the percentage on the front can hide those differences, especially when the alternative under consideration is described as a cream.
Facework reviews The Ordinary through its current manufacturer information, not a product trial of our own. Our publication is commercially affiliated with CoreAge Rx, which receives first placement in the linked shortlist. We do not turn that relationship into a claim against The Ordinary or an independent finding that CoreAge performs better.
In this article
The current name and size identify the product
The US manufacturer page calls this product Multi-Peptide + Copper Peptides 1% Serum and identifies its former name as Buffet plus Copper Peptides. The inspected 30 mL offer displays $28.80, reduced from $32. Those are current promotional and reference prices, not a promise that the reduction will persist or that every market has the same offer.
The page describes a water-based serum. Our cream-and-serum shortlist therefore records it as a serum rather than presenting it as another face cream. A bottle volume and a provider's multimonth supply claim are different pricing units; this review does not invent a usage duration to make them appear comparable.
The complete ingredient list is more useful than the hero ingredient
The online declaration starts with water and glycerin and includes Lactococcus Ferment Lysate, Copper Tripeptide-1, several additional peptides, hyaluronates and other ingredients. It also lists formulation components such as gums, preservatives and solvents. These details show a finished mixture rather than a single-ingredient experiment.
The manufacturer notes that formulas change and the website list may differ from a box depending on purchase date and region. The package guide explains why the actual supplied declaration still matters. A website list is valuable information, but this publication has not authenticated a batch or inspected a reader's bottle. No particular skin response can be assigned to one ingredient from the list alone.
One percent is not a comparison with an unidentified two percent
The product name specifies copper peptides at 1%, and the manufacturer describes GHK-Cu within its blend. That is more specific than a vague peptide headline, but it is not an independent assay performed by Facework. It also does not create a validated potency relationship with another company's differently documented formulation.
The percentage guide addresses that problem in the CoreAge cream review. A number alone cannot settle purity, the amount reaching a target, stability or clinical effect. FDA's labeling guide provides another useful boundary: ingredient order, with its stated exceptions, does not reveal every concentration. Reading the full formula is informative without turning it into an unsupported strength calculation.
Manufacturer compatibility advice belongs to this product
The page cautions against combining this serum with direct acids, retinoids or strong antioxidants such as direct vitamin C. It also limits use to unbroken skin and discusses irritation. Those are the manufacturer's instructions for its formulation; this review does not expand them into a universal chemical rule for all copper-peptide products.
A person using a prescription treatment or recovering from a procedure needs guidance appropriate to that situation rather than a layering schedule assembled here. The post-procedure guide explains why healing skin changes the evidence question. We provide no timing workaround, application frequency or substitute for product-specific professional advice, and the manufacturer's all-skin-types description is not a guarantee of individual tolerance.
Appearance claims do not identify the effect of copper alone
The Ordinary says the serum supports smoother-looking skin and the appearance of elasticity, firmness and fine lines. Its explanation invokes several peptide technologies, amino acids and hyaluronic ingredients. A change after using such a mixture would not by itself establish that copper caused the effect, even if copper features prominently in the name.
The reviewed page does not supply a published head-to-head comparison with Bounce Back or NIOD CAIS3. Nor did this publication audit the underlying reports for the brand's ingredient-technology claims. The NIOD review considers its separate product-testing summaries without treating different claims and methods as a common scoreboard. Similar language about firmness may describe different measurements or simply different marketing statements.
A serum may leave the moisturizer question open
The manufacturer presents this serum within a treatment stage rather than labeling it a complete replacement for every moisturizer. AAD's menopause guidance discusses dryness and the importance of appropriate moisturization as skin changes. It does not establish that this particular serum is sufficient for every reader, nor that a prescription cream is necessarily needed.
Our moisturizer-role guide separates that practical comfort question from a claim about collagen or visible firmness. A product's oil-free or water-based description does not tell this review exactly how it will feel on an individual's skin. We have not applied the product, measured hydration or compared texture with the other items in the shortlist.
A fair conclusion recognizes both information and limits
The Ordinary's page supplies an identifiable size, a current price, a detailed formula and product-specific cautions. Those are useful features of the public record. Its reformulation caveat, multi-ingredient design and lack of a verified comparative trial remain relevant limitations, rather than reasons to invent a positive or negative clinical rating.
FDA explains that cosmetics generally are not preapproved, while companies remain responsible for product safety and proper labeling. That context differs from an approved-drug finding and does not imply the product is automatically unsafe. Facework's conclusion is about the information available: a clearly described cosmetic serum that can be read alongside, but not silently equated with, a compounded cream offer.
Sources behind this reading
- The Ordinary: Multi-Peptide + Copper Peptides 1% Serum, US page ↗Manufacturer product page; direct HTML verifies ingredients and 30 mL variant · Checked 2026-09-27
- FDA: Cosmetics Labeling Guide ↗Regulator cosmetic-label guidance; not an exact compound label · Checked 2026-09-27
- American Academy of Dermatology: Caring for Your Skin in Menopause ↗Professional patient education; general skin-care context, not product testing · Checked 2026-09-27
- FDA: Cosmetics and US Law ↗Regulator explanation of cosmetic/drug and approval distinctions · Checked 2026-09-27